Coronavirus and High Dose Oxygen Therapy

Written by Ellen on October 29th, 2020June 24th, 2021.

A letter from Prof. Philip James. Hon. Medical Advisor MS Therapy Centres The way the (Corona) virus acts in the body is now understood and the receptors on the surface […]

Virtual Summer Fete 2020

Written by Ellen on July 2nd, 2020November 26th, 2020.

Swanley Therapy Centre’s annual Summer Fete fundraiser was originally planned for June 20th this year. Unfortunately due to the coronavirus outbreak affecting the whole country the event had to be […]

Effect of vitamin D supplements on MS activity

Written by Ellen on February 27th, 2020December 8th, 2021.

People with MS are often advised to take high doses of vitamin D, but there’s been very little research to assess what effect this might have.

Sign Up for Our Newsletter

Written by Ellen on February 5th, 2020July 2nd, 2022.

Subscribe * indicates required Email Address * First Name Last Name Marketing Permissions Swanley Therapy Centre will use the information you provide on this form to be in touch with […]

The Evidence for Oxygen awarded the 2019 Nobel prize

Written by Ellen on January 29th, 2020December 8th, 2021.

We wanted to draw attention to an interesting article published in the HBOTT Dec 2019 Newsletter.

Bowen Therapy at Swanley Therapy Centre

Written by Ellen on January 22nd, 2020November 26th, 2020.

Paul Dunn, an experienced Bowen Therapy practitioner, has started Bowen Therapy on Wednesday mornings. We will soon also have a second Bowen practitioner, Helen Malcolmson, starting on Thursday mornings.

Thank you to our supporters for 2020!

Written by Ellen on January 22nd, 2020July 2nd, 2020.

Fundraising, thank you to our supporters

Thank you to all the companies who have supported us so far this year, either by their financial contributions or by donating prizes for our Summer Fete Fundraising Event.

Tysabri: reducing the risk of PML with extended interval dosing

Written by Ellen on December 12th, 2019December 8th, 2021.

Tysabri (natalizumab) is very effective for people with highly active relapsing remitting MS but it carries the risk of developing a rare but very serious brain infection called progressive multifocal […]

Sativex approved by NICE

Written by Ellen on November 20th, 2019December 8th, 2021.

Sativex, a cannabis based drug for MS related spasticity, has been approved by NICE as a cost effective treatment for the NHS in England.

Siponimod recommended for secondary progressive MS by EMA

Written by Ellen on November 20th, 2019December 8th, 2021.

The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.